BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 16133860)

  • 1. Implantable defibrillators configured for hybrid therapy of persistent and permanent atrial fibrillation: initial clinical experience with a novel lead system.
    Rao HB; Saksena S
    J Interv Card Electrophysiol; 2005 Aug; 13 Suppl 1():79-86. PubMed ID: 16133860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of rhythm control in persistent or permanent atrial fibrillation with overdrive atrial pacing and antiarrhythmic drugs after linear right atrial catheter ablation.
    Filipecki A; Saksena S; Lin WH
    Am J Cardiol; 2003 Nov; 92(9):1037-44. PubMed ID: 14583353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term rhythm control of drug-refractory atrial fibrillation with "hybrid therapy" incorporating dual-site right atrial pacing, antiarrhythmic drugs, and right atrial ablation.
    Madan N; Saksena S
    Am J Cardiol; 2004 Mar; 93(5):569-75. PubMed ID: 14996581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left atrial reverse remodeling and prevention of progression of atrial fibrillation with atrial resynchronization device therapy utilizing dual-site right atrial pacing in patients with atrial fibrillation refractory to antiarrhythmic drugs or catheter ablation.
    Nagarakanti R; Slee A; Saksena S
    J Interv Card Electrophysiol; 2014 Sep; 40(3):245-54. PubMed ID: 25080310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrial fibrillation reduces the atrial impedance amplitude during cardiac cycle: a novel detection algorithm to improve recognition of atrial fibrillation in pacemaker patients.
    Schmidt B; Asbach S; Schweika O; Zehender M; Bode C; Faber TS
    Europace; 2007 Sep; 9(9):812-6. PubMed ID: 17545214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of "hybrid therapy" on long-term rhythm control and arrhythmia related hospitalizations in patients with drug-refractory persistent and permanent atrial fibrillation.
    Rao BH; Saksena S
    J Interv Card Electrophysiol; 2007 Mar; 18(2):127-36. PubMed ID: 17372812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Box Isolation of Fibrotic Areas (BIFA): A Patient-Tailored Substrate Modification Approach for Ablation of Atrial Fibrillation.
    Kottkamp H; Berg J; Bender R; Rieger A; Schreiber D
    J Cardiovasc Electrophysiol; 2016 Jan; 27(1):22-30. PubMed ID: 26511713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonpharmacologic strategies for treating atrial fibrillation.
    Lüderitz B; Pfeiffer D; Tebbenjohanns J; Jung W
    Am J Cardiol; 1996 Jan; 77(3):45A-52A. PubMed ID: 8607391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical experience with a dual-chamber implantable cardioverter defibrillator to treat atrial tachyarrhythmias.
    Gold MR; Sulke N; Schwartzman DS; Mehra R; Euler DE;
    J Cardiovasc Electrophysiol; 2001 Nov; 12(11):1247-53. PubMed ID: 11761411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary vein antral isolation and nonpulmonary vein trigger ablation without additional substrate modification for treating longstanding persistent atrial fibrillation.
    Lin D; Frankel DS; Zado ES; Gerstenfeld E; Dixit S; Callans DJ; Riley M; Hutchinson M; Garcia F; Bala R; Verdino R; Cooper J; Marchlinski FE
    J Cardiovasc Electrophysiol; 2012 Aug; 23(8):806-13. PubMed ID: 22509772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of rapid atrial pacing for termination of drug refractory atrial fibrillation: results of a dual chamber implantable cardioverter defibrillator trial.
    Gold MR; Leman RB; Euler DE
    Card Electrophysiol Rev; 2003 Dec; 7(4):341-4. PubMed ID: 15071249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Atrial defibrillator].
    Jung W; Lüderitz B
    Z Kardiol; 2000; 89 Suppl 3():206-14. PubMed ID: 10810804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility and Efficacy of His Bundle Pacing or Left Bundle Pacing Combined With Atrioventricular Node Ablation in Patients With Persistent Atrial Fibrillation and Implantable Cardioverter-Defibrillator Therapy.
    Wang S; Wu S; Xu L; Xiao F; Whinnett ZI; Vijayaraman P; Su L; Huang W
    J Am Heart Assoc; 2019 Dec; 8(24):e014253. PubMed ID: 31830874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Inadequate therapies with implantable cardioverter-defibrillators--incidence, etiology, predictive factors and preventive strategies].
    Weber M; Block M; Brunn J; Bänsch D; Böcker D; Hammel D; Gietzen F; Breithardt G
    Z Kardiol; 1996 Nov; 85(11):809-19. PubMed ID: 9064943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hybrid therapy of atrial fibrillation.
    Santini M; Pignalberi C; Ricci R; Calò L
    Ital Heart J; 2002 Oct; 3(10):571-8. PubMed ID: 12478814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of atrial fibrillation with rapid ventricular rates and device programming on shocks in 106,513 ICD and CRT-D patients.
    Fischer A; Ousdigian KT; Johnson JW; Gillberg JM; Wilkoff BL
    Heart Rhythm; 2012 Jan; 9(1):24-31. PubMed ID: 21835150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pace-termination and pacing for prevention of atrial tachyarrhythmias: results from a multicenter study with an implantable device for atrial therapy.
    Israel CW; Hügl B; Unterberg C; Lawo T; Kennis I; Hettrick D; Hohnloser SH;
    J Cardiovasc Electrophysiol; 2001 Oct; 12(10):1121-8. PubMed ID: 11699520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Septal atrial pacing for the prevention of atrial fibrillation.
    Hakacova N; Velimirovic D; Margitfalvi P; Hatala R; Buckingham TA
    Europace; 2007 Dec; 9(12):1124-8. PubMed ID: 18024494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biatrial pacing as an effective therapy method of paroxysmal atrial fibrillation].
    Witte J; Reibis R; Bondke HJ; Baumann G
    Wien Med Wochenschr; 2000; 150(19-21):419-23. PubMed ID: 11132436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atrioventricular junction ablation in patients with atrial fibrillation treated with cardiac resynchronization therapy: positive impact on ventricular arrhythmias, implantable cardioverter-defibrillator therapies and hospitalizations.
    Gasparini M; Kloppe A; Lunati M; Anselme F; Landolina M; Martinez-Ferrer JB; Proclemer A; Morani G; Biffi M; Ricci R; Rordorf R; Mangoni L; Manotta L; Grammatico A; Leyva F; Boriani G
    Eur J Heart Fail; 2018 Oct; 20(10):1472-1481. PubMed ID: 29251799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.